梅毒检测市场：按梅毒类型、检测方法、检体地点、样本类型、产品形式、技术、最终用户和地区划分

预计到 2025 年，梅毒检测市场价值将达到 11.9 亿美元，到 2032 年将达到 26.1 亿美元，2025 年至 2032 年的复合年增长率为 11.9%。

全球梅毒检测市场是整个感染疾病诊断产业的重要组成部分，主要关注梅毒的检测和诊断，梅毒是一种由梅毒螺旋体引起的性行为感染传染病。

梅毒检测包括多种调查方法，例如传统的血清学检测、快速诊断检测以及先进的分子诊断技术，例如基于PCR的检测。儘管梅毒是一种可以透过适当的抗生素治疗治癒的感染疾病，但由于全球范围内，特别是已开发国家梅毒病例的再次出现，该市场正受到广泛关注。

世界各地的医疗卫生系统正在实施全面的筛检计划，尤其关注高风险族群、孕妇和有多个性伴侣的人群，这推动了对准确快速诊断解决方案的需求。检测方法包括梅毒螺旋体检测和非梅毒螺旋体检测，每种检测方法在感染的不同阶段都发挥特定的诊断作用。

就地检验设备透过提供即时结果，彻底改变了梅毒的诊断方式，使其在资源匮乏地区和急诊室尤为重要。数位健康技术和实验室自动化的整合进一步提高了检测效率和结果准确性。公共卫生倡议、监管指南以及公众对性行为感染日益增长的认识，持续影响着市场动态，凸显了早期发现和治疗对于预防疾病进展和传播的重要性。

市场动态

全球梅毒检测市场的成长主要受全球梅毒发病率惊人上升的推动。世界卫生组织（世卫组织）报告称，已开发国家的病例显着增加，这迫切需要全面的检测解决方案。人们对性行为感染传染病及其长期健康后果（包括先天性梅毒的传播）的认识不断提高，促使筛检计画扩大规模，并在医疗机构实施常规检测通讯协定。

政府政策，例如推广性健康教育和强制孕妇进行性健康检测，是推动成长要素。同时，快速诊断测试和分子诊断技术的进步提高了检测准确性，缩短了出结果的时间。在偏远和医疗资源匮乏地区，就地检验设备的日益普及有助于解决可近性问题，并促进市场扩张。

然而，市场仍存在诸多限制因素，包括与性行为感染传染病相关的社会污名，这往往导致检测率低和诊断延迟。先进诊断设备的高成本以及发展中地区医疗基础设施的匮乏，都构成了市场渗透的重大障碍。此外，诊断设备核准的复杂法规以及各国不同的检测指南也为市场相关人员带来了额外的挑战。

儘管有这些限制，但创新检测技术的发展仍蕴藏着巨大的机会，例如基于智慧型手机的诊断解决方案和用于结果解读的整合人工智慧平台。远端医疗领域的蓬勃发展为远距检测咨询和后续服务开闢了新的途径。诊断公司与医疗服务提供者之间的策略合作，以及政府和非政府组织对性健康项目的投入不断增加，正在为市场成长创造有利条件，尤其是在梅毒高发且检测基础设施亟待发展的新兴经济体。

本次调查的主要特点

• 本报告对全球梅毒检测市场进行了详细分析，以 2024 年为基准年，给出了预测期（2025-2032 年）内的市场规模（十亿美元）和復合年增长率（%）。
• 该报告还重点介绍了各个细分市场的潜在商机，并概述了该市场具有吸引力的投资提案矩阵。
• 该研究还提供了有关市场驱动因素、阻碍因素、机会、新产品发布或核准、市场趋势、区域展望以及主要企业采取的竞争策略的重要见解。
• 该报告根据以下参数对全球梅毒检测市场的主要企业进行了分析：公司概况、产品系列、主要亮点、财务表现和策略。
• 本报告的研究结果将使负责人和企业经营团队能够就未来的产品发布、类型升级、市场扩张和行销策略做出明智的决策。
• 本报告的目标受众是全球梅毒检测市场的各个相关人员，包括投资者、供应商、产品製造商、经销商、新参与企业和金融分析师。
• 相关人员可以透过用于分析全球梅毒检测市场的各种策略矩阵轻鬆做出决策。

目录

第一章：调查目标和前提条件

• 调查目的
• 先决条件
• 简称

第二章 市场展望

• 报告说明
  • 市场定义和范围
• 执行摘要

第三章：市场动态、监管与趋势分析

• 市场动态
• 司机
• 抑制因素
• 机会
• 影响分析
• 重大进展
• 监管情景
• 产品发布/核准
• PEST分析
• 波特五力分析
• 併购情景
• 产业趋势

4. 2020-2032年全球梅毒检测市场（以梅毒类型划分）

• 一期和二期梅毒
• 潜伏期和第三期梅毒

5. 2020-2032年全球梅毒检测市场（依检测方法划分）

• 血清学检测
• 非梅毒螺旋体检测（例如，RPR、VDRL）
• 密螺旋体测试（例如 TPHA、FTA-ABS）
• 分子诊断
• 核酸增幅检查（NAATs）
• 聚合酵素链锁反应（PCR）

6. 2020-2032年全球梅毒检测市场（依检测地点划分）

• 实验室测试
• 照护现场侦测 (POC)

7. 2020-2032年全球梅毒检测市场（依检体类型划分）

• 血清/血浆
• 全血
• 口腔液
• 干血迹（DBS）

8. 2020-2032年全球梅毒检测市场（依产品类型划分）

• 诊断试剂套件
• 试剂和耗材
• 测量和分析设备

9. 全球梅毒检测市场（依技术划分），2020-2032年

• 酵素免疫分析法（ELISA）
• 化学冷光免疫检测（CLIA）
• 横向流动化验（LFA）
• 快速血浆反应素（RPR）
• 密螺旋体颗粒凝集试验（TPPA）

10. 全球梅毒检测市场（依最终用户划分），2020-2032 年

• 医院
• 诊断实验室
• 照护现场(POC) 设定
• 居家护理/自测
• 其他（学术研究机构）

第十一章 全球梅毒检测市场（按地区划分），2020-2032年

• 北美洲
  • 美国
  • 加拿大
• 拉丁美洲
  • 巴西
  • 阿根廷
  • 墨西哥
  • 其他拉丁美洲
• 欧洲
  • 德国
  • 英国
  • 西班牙
  • 法国
  • 义大利
  • 俄罗斯
  • 其他欧洲
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国
  • ASEAN
  • 亚太其他地区
• 中东
  • 海湾合作委员会国家
  • 以色列
  • 其他中东地区
• 非洲
  • 南非
  • 北非
  • 中非

第十二章 竞争格局

• Roche Diagnostics
• Abbott Laboratories
• BD（Becton, Dickinson and Company）
• Siemens Healthineers
• bioMerieux
• Hologic
• Cepheid
• Bio-Rad Laboratories
• Thermo Fisher Scientific
• Ortho Clinical Diagnostics
• QuidelOrtho
• Trinity Biotech
• SD Biosensor
• Healgen Scientific
• Mologic

第十三章 分析师建议

• 机会
• 分析师观点
• Coherent Opportunity Map

第十四章 参考文献与调查方法

• 参考
• 调查方法
• 关于出版商

Syphilis Testing Market is estimated to be valued at USD 1.19 Bn in 2025 and is expected to reach USD 2.61 Bn by 2032, growing at a compound annual growth rate (CAGR) of 11.9% from 2025 to 2032.

The global syphilis testing market represents a critical segment within the broader infectious disease diagnostics industry, focusing on the detection and diagnosis of syphilis, a sexually transmitted infection caused by the bacterium Treponema pallidum.

Syphilis testing encompasses various diagnostic methodologies including traditional serological tests, rapid diagnostic tests, and advanced molecular diagnostic techniques such as PCR-based assays. The market has gained significant attention due to the resurgence of syphilis cases worldwide, particularly in developed countries, despite being a curable infection with appropriate antibiotic treatment.

Healthcare systems globally are implementing comprehensive screening programs, especially for high-risk populations, pregnant women, and individuals with multiple sexual partners, driving the demand for accurate and rapid diagnostic solutions. The testing landscape includes both treponemal and non-treponemal tests, each serving specific diagnostic purposes in different stages of infection.

Point-of-care testing devices have revolutionized syphilis diagnosis by providing immediate results, particularly beneficial in resource-limited settings and emergency departments. The integration of digital health technologies and laboratory automation has further enhanced testing efficiency and result accuracy. Public health initiatives, regulatory guidelines, and increasing awareness about sexually transmitted infections continue to shape the market dynamics, emphasizing the importance of early detection and treatment to prevent disease progression and transmission.

Market Dynamics

The global syphilis testing market is primarily driven by the alarming rise in syphilis incidence rates worldwide, with the World Health Organization reporting significant increases in developed nations, creating urgent demand for comprehensive testing solutions. Growing awareness about sexually transmitted infections and their long-term health consequences, including congenital syphilis transmission, has led to expanded screening programs and routine testing protocols in healthcare facilities.

Government initiatives promoting sexual health education and mandatory testing for pregnant women serve as key growth catalysts, while technological advancements in rapid diagnostic tests and molecular diagnostics have improved testing accuracy and reduced turnaround times. The increasing adoption of point-of-care testing devices in remote and underserved areas addresses accessibility challenges and supports market expansion.

However, the market faces significant restraints including social stigma associated with sexually transmitted infections, which often leads to reduced testing compliance and delayed diagnosis. High costs of advanced diagnostic equipment and limited healthcare infrastructure in developing regions pose substantial barriers to market penetration. Regulatory complexities surrounding diagnostic device approvals and varying testing guidelines across different countries create additional challenges for market players.

Despite these constraints, substantial opportunities exist in the development of innovative testing technologies, including smartphone-based diagnostic solutions and artificial intelligence-integrated platforms for result interpretation. The expanding telemedicine sector presents new avenues for remote testing consultation and follow-up services. Strategic partnerships between diagnostic companies and healthcare providers, along with increasing investments in sexual health programs by government and non-government organizations, create favorable conditions for market growth, particularly in emerging economies where syphilis prevalence remains high and testing infrastructure requires significant development.

Key Features of the Study

• This report provides in-depth analysis of the global syphilis testing market, and provides market size (USD Billion) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global syphilis testing market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
• Key companies covered as a part of this study include Roche Diagnostics, Abbott Laboratories, BD (Becton, Dickinson and Company), Siemens Healthineers, bioMerieux, Hologic, Cepheid, Bio-Rad Laboratories, Thermo Fisher Scientific, Ortho Clinical Diagnostics, QuidelOrtho, Trinity Biotech, SD Biosensor, Healgen Scientific, and Mologic
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• The global syphilis testing market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global syphilis testing market

Market Segmentation

• Type of Syphilis Insights (Revenue, USD Bn, 2020 - 2032)
  • Primary and Secondary Syphilis
  • Latent and Tertiary Syphilis
• Test Methodology Insights (Revenue, USD Bn, 2020 - 2032)
  • Serological Tests
  • Non-Treponemal Tests (e.g., RPR, VDRL)
  • Treponemal Tests (e.g., TPHA, FTA-ABS)
  • Molecular Diagnostics
  • Nucleic Acid Amplification Tests (NAATs)
  • Polymerase Chain Reaction (PCR)
• Location of Testing Insights (Revenue, USD Bn, 2020 - 2032)
  • Laboratory Testing
  • Point-of-Care (POC) Testing
• Specimen Type Insights (Revenue, USD Bn, 2020 - 2032)
  • Serum/Plasma
  • Whole Blood
  • Oral Fluid
  • Dried Blood Spot (DBS)
• Product Format Insights (Revenue, USD Bn, 2020 - 2032)
  • Diagnostic Kits
  • Reagents and Consumables
  • Instruments and Analyzers
• Technology Insights (Revenue, USD Bn, 2020 - 2032)
  • Enzyme-Linked Immunosorbent Assay (ELISA)
  • Chemiluminescent Immunoassay (CLIA)
  • Lateral Flow Assays (LFA)
  • Rapid Plasma Reagin (RPR)
  • Treponemal Particle Agglutination (TPPA)
• End User Insights (Revenue, USD Bn, 2020 - 2032)
  • Hospitals
  • Diagnostic Laboratories
  • Point-of-Care (POC) Settings
  • Home Care/Self-Testing
  • Others (Academic and Research Institutes)
• Regional Insights (Revenue, USD Bn, 2020 - 2032)
  • North America
  • U.S.
  • Canada
  • Latin America
  • Brazil
  • Argentina
  • Mexico
  • Rest of Latin America
  • Europe
  • Germany
  • U.K.
  • Spain
  • France
  • Italy
  • Russia
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
  • Middle East
  • GCC Countries
  • Israel
  • Rest of Middle East
  • Africa
  • South Africa
  • North Africa
  • Central Africa
• Key Players Insights
  • Roche Diagnostics
  • Abbott Laboratories
  • BD (Becton, Dickinson and Company)
  • Siemens Healthineers
  • bioMerieux
  • Hologic
  • Cepheid
  • Bio-Rad Laboratories
  • Thermo Fisher Scientific
  • Ortho Clinical Diagnostics
  • QuidelOrtho
  • Trinity Biotech
  • SD Biosensor
  • Healgen Scientific
  • Mologic

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Global Syphilis Testing Market, By Type of Syphilis
  • Global Syphilis Testing Market, By Test Methodology
  • Global Syphilis Testing Market, By Location of Testing
  • Global Syphilis Testing Market, By Specimen Type
  • Global Syphilis Testing Market, By Product Format
  • Global Syphilis Testing Market, By Technology
  • Global Syphilis Testing Market, By End User
  • Global Syphilis Testing Market, By Region

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
• Driver
• Restraint
• Opportunity
• Impact Analysis
• Key Developments
• Regulatory Scenario
• Product Launches/Approvals
• PEST Analysis
• PORTER's Analysis
• Merger and Acquisition Scenario
• Industry Trends

4. Global Syphilis Testing Market, By Type of Syphilis, 2020-2032, (USD Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Primary and Secondary Syphilis
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Latent and Tertiary Syphilis
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

5. Global Syphilis Testing Market, By Test Methodology, 2020-2032, (USD Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Serological Tests
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Non-Treponemal Tests (e.g., RPR, VDRL)
• Treponemal Tests (e.g., TPHA, FTA-ABS)
• Molecular Diagnostics
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Nucleic Acid Amplification Tests (NAATs)
• Polymerase Chain Reaction (PCR)

6. Global Syphilis Testing Market, By Location of Testing, 2020-2032, (USD Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Laboratory Testing
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Point-of-Care (POC) Testing
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

7. Global Syphilis Testing Market, By Specimen Type, 2020-2032, (USD Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Serum/Plasma
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Whole Blood
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Oral Fluid
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Dried Blood Spot (DBS)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

8. Global Syphilis Testing Market, By Product Format, 2020-2032, (USD Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Diagnostic Kits
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Reagents and Consumables
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Instruments and Analyzers
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

9. Global Syphilis Testing Market, By Technology, 2020-2032, (USD Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Enzyme-Linked Immunosorbent Assay (ELISA)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Chemiluminescent Immunoassay (CLIA)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Lateral Flow Assays (LFA)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Rapid Plasma Reagin (RPR)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Treponemal Particle Agglutination (TPPA)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

10. Global Syphilis Testing Market, By End User, 2020-2032, (USD Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Hospitals
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Diagnostic Laboratories
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Point-of-Care (POC) Settings
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Home Care/Self-Testing
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Others (Academic and Research Institutes)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

11. Global Syphilis Testing Market, By Region, 2020 - 2032, Value (USD Bn)

• Introduction
  • Market Share (%) Analysis, 2025, 2028 & 2032, Value (USD Bn)
  • Market Y-o-Y Growth Analysis (%), 2021 - 2032, Value (USD Bn)
  • Regional Trends
• North America
  • Introduction
  • Market Size and Forecast, By Type of Syphilis, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Test Methodology, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Location of Testing, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Specimen Type, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Product Format, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Technology , 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
    • U.S.
    • Canada
• Latin America
  • Introduction
  • Market Size and Forecast, By Type of Syphilis, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Test Methodology, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Location of Testing, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Specimen Type, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Product Format, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Technology , 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
• Europe
  • Introduction
  • Market Size and Forecast, By Type of Syphilis, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Test Methodology, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Location of Testing, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Specimen Type, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Product Format, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Technology , 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, By Type of Syphilis, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Test Methodology, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Location of Testing, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Specimen Type, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Product Format, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Technology , 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
• Middle East
  • Introduction
  • Market Size and Forecast, By Type of Syphilis, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Test Methodology, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Location of Testing, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Specimen Type, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Product Format, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Technology , 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
    • GCC Countries
    • Israel
    • Rest of Middle East
• Africa
  • Introduction
  • Market Size and Forecast, By Type of Syphilis, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Test Methodology, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Location of Testing, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Specimen Type, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Product Format, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Technology , 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Country/Region, 2020 - 2032, Value (USD Bn)
    • South Africa
    • North Africa
    • Central Africa

12. Competitive Landscape

• Roche Diagnostics
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Abbott Laboratories
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• BD (Becton, Dickinson and Company)
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Siemens Healthineers
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• bioMerieux
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Hologic
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Cepheid
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Bio-Rad Laboratories
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Thermo Fisher Scientific
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Ortho Clinical Diagnostics
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• QuidelOrtho
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Trinity Biotech
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• SD Biosensor
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Healgen Scientific
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Mologic
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies

13. Analyst Recommendations

• Wheel of Fortune
• Analyst View
• Coherent Opportunity Map

14. References and Research Methodology

• References
• Research Methodology
• About us